Cannabinoids
- PMID: 32310522
- Bookshelf ID: NBK556062
Cannabinoids
Excerpt
Cannabinoids are biologically active compounds used in the management and treatment of appetite/weight loss from HIV/AIDS and chemotherapy in addition to epilepsy. According to the Food and Drug Administration, it is in the anti-emetics and anti-epileptic class of medications per the Food and Drug Administration. This activity outlines the indications, mechanism of action, and contraindications for cannabinoids as a valuable agent in managing the before-mentioned diseases. Moreover, this activity will highlight the mechanism of action, adverse event profile, and other key factors (eg, off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, and relevant interactions) pertinent to members of the interprofessional team in the management of patients with appetite or weight loss or epilepsy.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
References
-
- Zias J, Stark H, Sellgman J, Levy R, Werker E, Breuer A, Mechoulam R. Early medical use of cannabis. Nature. 1993 May 20;363(6426):215. - PubMed
-
- McPartland JM, Agraval J, Gleeson D, Heasman K, Glass M. Cannabinoid receptors in invertebrates. J Evol Biol. 2006 Mar;19(2):366-73. - PubMed
-
- Mechoulam R, Fride E, Di Marzo V. Endocannabinoids. Eur J Pharmacol. 1998 Oct 16;359(1):1-18. - PubMed
-
- Romero-Sandoval EA, Kolano AL, Alvarado-Vázquez PA. Cannabis and Cannabinoids for Chronic Pain. Curr Rheumatol Rep. 2017 Oct 05;19(11):67. - PubMed
Publication types
LinkOut - more resources
Full Text Sources